S ystemic lupus erythematosus (SLE) is a complex autoimmune disease with limited treatment options (1, 2).
Although progress has been made in understanding the underlying pathogenesis of this disease, including the hallmark contributions of anti-nuclear autoantibodies (3) (4) (5) , chronic elevation of IFN-a (6-10), and accumulated apoptotic bodies (11) (12) (13) , how these modular mechanisms are activated and rally toward SLE disease remains poorly understood. Anti-nuclear autoantibodies are early pathogenic factors that can manifest long before SLE disease onset, whereas IFN-a and apoptotic cellular Ags appear to surge at disease flare (1, 3, 14, 15) . The primary causes of anti-nuclear autoantibodies remain unclear, and understanding their origins can greatly expand therapeutic options.
In live cells, nuclear Ags are segregated from autologous immune cell recognition and responses. Early apoptotic cells similarly conceal these Ags, and also actively suppress proinflammatory responses from phagocytes and other immune cells (16) . However, exposure of these intracellular materials can occur when cell death takes the necrotic pathway (17, 18) . The naive B cell repertoire contains significant autoreactive B cells (19) . The autoimmunogenicity of nuclear materials has been demonstrated when anti-nuclear autoantibodies were found induced following the injection of dead cells into mice (11, 20) . This was especially prominent when adjuvant was also injected (20) . This reaction inevitably involves intracellular autoantigens and potentially intracellular adjuvants such as IL-1a, IL-33, S100 proteins or high mobility group box 1 (HMGB1), which are also known as danger-associated molecular patterns (DAMPs) or alarmins (18, 21, 22) . Incidentally, HMGB1 is released in complex with chromatin fragments from necrotic cells, which induces lupus-like antinuclear responses in mice (21) .
Genetic studies have revealed .50 SLE risk genes, broadly related to inflammation, immune clearance, and IFN-a-producing or signaling pathways (23) (24) (25) . These risk genes mostly exhibit low-to-moderate impacts on SLE disease and are mostly not specific for SLE pathogenesis. More than 20 monogenic SLE risk genes have also been reported, which also broadly impact on other autoimmune diseases (26) . However, genetic deficiencies in a group of complement proteins (i.e., C1q, C1r/C1s, and C4) show strong and highly specific association with SLE pathogenesis (23, (27) (28) (29) . These patients develop anti-nuclear autoantibodies and manifest severe SLE disease characterized by early disease onset and equal gender susceptibility. These complement proteins are intimately related; C1q, C1r, and C1s form the C1 (C1qC1r 2 C1s 2 ) complex in which C1q is a scaffold, and C1r and C1s are effector serine proteases (30, 31) . C1 complex defines the complement classical pathway: binding of C1q to Ag-bound Abs causes activation of C1r followed by C1s, which subsequently cleaves C4 and C2 to trigger the complement cascade (32) .
The strong causal association between C1 or C4 deficiency and SLE pathogenesis cannot be explained in the traditional paradigm of the complement system, which consists of nearly 30 plasma proteins (23, 28) . C2 deficiency is relatively common and also contributes to SLE pathogenesis (27, 33) . However, it lacks the type of strong and specific effect, early disease onset, and equal gender susceptibility found with C1 and C4 deficiencies. In some patients, C1 inhibitor (C1-inh) deficiency can manifest mild SLElike conditions, and this could be explained by excessive C1r or C1s activation and consumption of intimately related complement elements because serum C1q, C1s, C4, and C2 levels appeared to be reduced in these patients (34) (35) (36) . In the Japanese population, C3-deficient patients were reported with clinical SLE-like presentations, although immunological presentations were either absent or mild (37, 38) . Genetic deficiencies in most other complement proteins are not significant risk factors for SLE (39) . A possible context to understand the strong causal association between C1/C4 deficiency and SLE pathogenesis revolves around the ability of C1q to recognize dead cells (30, 31, 40) and the ability of both C1q and activated C4 to opsonize dead cells for immune clearance (13, 41) . Because apoptotic bodies are known to accumulate in SLE patients and, in mice, injection of dead cells causes antinuclear autoimmunity (11, 13, 41, 42) , the clearance functions of C1q and C4 are clearly relevant to SLE pathogenesis. However, other mechanisms may also be important by which these complement proteins increase host tolerance to autologous nuclear Ags, for example, C1q regulation of dendritic cells (DCs) and C4-mediated B cell inhibition or tolerance (13, (43) (44) (45) (46) . How C1r/C1s deficiency causes SLE has been mainly intuited based on studies of C1q and C4 (28, 47) .
In determining C1q binding sites in dead cells, we recently observed that C1q bound to the cell periphery in early apoptosis, but it bound predominantly to the nucleoli during late apoptosis (48) . Isolated nucleoli were also recognized by C1q, causing activation of the C1s protease and the cleavage of two major nucleolar proteins, nucleophosmin-1 (NPM1) and nucleolin (NCL) (48) . Because anti-nucleolus autoantibodies are prevalent in SLE patients and are also significant autoantibody specificities in SLE mice and some cancer patients (49) (50) (51) (52) , in this study, we estimated the extent of nucleolar protein and autoantigen degradation by C1 proteases through a proteomic approach.
Materials and Methods

Cell culture and Abs
Human cervical adenocarcinoma HeLa cells were cultured in DMEM containing 10% (v/v) HyClone FBS, 100 U/ml penicillin, 100 mg/ml streptomycin, and 2 mM L-glutamine at 37˚C and 5% CO 2 . Mouse anti-NPM1 (B0556) and rabbit anti-DDX5 (HPA020043) Abs were purchased from Sigma-Aldrich (St. Louis, MO). Rabbit Abs for NCL (ab22758), fibrillarin (ab5821), hnRNPC (ab97541), DDX21 (ab126968), BOP1 (ab86982), EIF2S1 (ab26197), RRP9 (ab168845), RPL30 (ab170930), SFPQ (ab38148), and hnRNPA2B1 (ab6102) were obtained from Abcam (Cambridge, U.K.). Goat anti-C1q (A301) and anti-C1s (A302) Abs were purchased from Quidel (San Diego, CA). A rabbit anti-human histone H3 Ab (9715), the C1 complex (204873), and the C1-inh (204883) were purchased from Merck Millipore (Billerica, MA). For most Ags, gene symbols are used with full names being detailed in Tables I and II . Nuclei were sonicated and centrifuged at 2500 3 g for 2 min, to collect the supernatant as nuclear ghost 1 (NG1) and, after resuspension in 0.88 M sucrose containing 5.0 mM MgCl 2 and 10 mM Tris (pH 7.4), centrifuged for FIGURE 1. Anti-nucleolus autoantibodies are broadly detected in SLE patients. (A) Schematic illustration of nucleoli and nuclear ghost fractions isolated from HeLa cells. (B) Two nucleoplasmic fractions, derived during nucleolus isolation (NG1 and NG2), were compared with isolated nucleoli (nucleolus) in protein profiles (total protein). Samples were normalized to OD280 reading of 2.0; then each sample was loaded at 12 ml. Autoantigens in these three fractions were detected by Western blotting using 14 SLE patient IgG autoantibodies (SLE37-50). IgG was also isolated from a normal human serum and used as a control. Representative data are shown for at least two independent experiments. 5 min at 1000 3 g to collect the supernatant as NG2. The crude nucleoli were centrifuged through a 0.85-to 2.5-M sucrose gradient for 2 h at 100,000 3 g (Fig. 1A) . The pelleted nucleoli are resuspended in the 0.25-M sucrose buffer, giving rise to A280 readings from 2.0 to 4.0.
Isolation of nucleoli
Confocal microscopy
Isolated nucleoli (5 ml) were incubated for 5 min on ice with 12-mm glass coverslips and fixed for 30 min in 1% (w/v) paraformaldehyde. The coverslips were briefly washed and immunostained for 30 min with anti-NPM1 and then for 30 min with goat anti-mouse IgG (Cy3). Coverslips were mounted with DAPI-containing VECTASHIELD medium and viewed using the FluoView FV1000 confocal microscope equipped with a 1003 oil objective (aperture 1.45) and Cool/SNAP HQ2 image acquisition camera (Olympus). Images were captured with the FV-ASW 1.6b software and analyzed using the Imaris software (Bitplane AG).
Scanning electron microscopy
Coverslip-bound nucleoli were also fixed for 2 h in 2.5% (v/v) glutaraldehyde and, after washing in PBS, oxidized for 30 min in 1% (w/v) OsO 4 (pH 7.4). Dehydration was performed at rising ethanol concentrations (i.e., 50, 75, 95, and 100%). The samples were equilibrated with liquid CO 2 using an EM CPD 030 Critical Point Dryer (Leica Camera AG, Wetzlar, Germany). After gold-sputtering with a Leica BAL-TEC SCD 005 Sputter Coater (100 s at 30 mA), images were acquired at 10 KVand 20 mA emission current, using a JSM-6701F Field Emission Scanning Microscope (JOEL, Tokyo, Japan).
C1 treatment of nucleoli
Treatments were performed in 50-ml reactions, that is, 25 ml of purified nucleoli (OD 280 = 2.0) and 25 ml of C1 dilution (19.2 mg/ml) in 10 mM Tris, 150 mM NaCl, and 3.3 mM CaCl 2 (pH 7.4). C1 was stored at 270˚C in an acidic buffer (300 mM NaCl, 50 mM sodium acetate, 50 mM ε amino caproic acid, 25 mM p-nitrophenyl-p9-guanido benzoate, 10 mM benzamidine, 10 mM EDTA, 40% [v/v] glycerol [pH 5.5]) and diluted immediately before use. After incubation at 37˚C for up to 2 h, reactions were stopped using SDS-PAGE sample buffer and analyzed by SDS-PAGE and Western blotting. Where C1-inh was used, 12.5 ml of C1 (38.4 mg/ml) was first premixed with 12.5 ml of C1-inh (320 mg/ml) on ice. This was then incubated with 25 ml of nucleoli.
SLE patient autoantibodies
Plasma samples were obtained from SLE patients in the Tan Tock Seng Hospital, Singapore, with Institutional Ethics approval. All patients fulfilled the diagnosis according to the 1982 American College of Rheumatology criteria for SLE (53) . IgG was isolated from these plasma samples using the HiTrap Protein G columns (GE Healthcare) and used in Western blotting.
Western blotting
Samples were separated on 12.5% (w/v) SDS-PAGE gels, and the blots were, after blocking for 1 h in TBS-T (50 mM Tris, 150 mM NaCl [pH 7.4], and 0.1% [v/v] Tween 20) containing 5% [w/v] nonfat milk, incubated overnight at 4˚C with specific Abs (10 mg/ml). After washing, the blots were incubated for 2 h with HRP-conjugated secondary Abs. Signals were visualized using the West Dura Extended Duration substrate (Thermo Scientific).
Two-dimensional fluorescence difference gel electrophoresis
These experiments were performed with assistance from Applied Biomics (Hayward, CA). Nucleoli were incubated with C1 for 2 h at 37˚C or 4˚C. The two samples (∼200 mg each) were each dissolved in 0.2 ml of a cell lysis buffer (30 mM Tris-HCl [pH 8.8] containing 7 M urea, 2 M thiourea, and 4% CHAPS). The samples were sonicated on ice, mixed for 30 min at room temperature, and cleared by centrifugation for 30 min at 4˚C and 25,000 3 g. Thirty micrograms of each protein lysate was labeled in the dark for 30 min on ice with 1.0 ml of 0.2 mM Cy2 (4˚C sample) and Cy5 (37˚C sample). After adding 1.0 ml of 10 mM lysine and 15-min incubation on ice, the samples were combined and then mixed with 23 2D sample buffer (8 M urea, 4% CHAPS, 20 mg/ml DTT, 2% pharmalytes, and trace amount of bromophenol blue). One hundred microliters of DeStreak solution and rehydration buffer (7 M urea, 2 M thiourea, 4% CHAPS, 20 mg/ml DTT, 1% pharmalytes, and trace amount of bromophenol blue) was added for the 18-cm immobilized pH gradient strip. After mixing and centrifugation, these samples were loaded into the strip holder for isoelectric focusing and SDS-PAGE separation. Images were scanned using Typhoon TRIO and analyzed using the Image QuantTL software (GE Healthcare). Gels were analyzed using the DeCyder software version 6.5 (GE Healthcare).
MALDI-TOF and TOF/TOF tandem mass spectrometry
Spots were picked using the Ettan Spot Picker facilitated by the DeCyder software and, after washing, in-gel digested using the protease Trypsin Gold (Promega). A spot was considered C1-cleaved if it disappeared or was markedly reduced in the 37˚C sample. After desalting on Zip-tip C18 (Millipore), the tryptic peptides were eluted with 0.5 ml of matrix solution (a-cyano-4-hydroxycinnamic acid, 5 mg/ml in 50% acetonitrile, 0.1% trifluoroacetic acid, 25 mM ammonium bicarbonate) and spotted on the MALDI plate for MALDI-TOF mass spectrometry and TOF/TOF tandem mass spectrometry analyses using the 5800 Mass Spectrometer (AB Sciex).
The resultant peptide mass and fragmentation spectra were submitted to GPS Explorer (version 3.5) equipped with the MASCOT search engine (Matrix Science) to search the NCBInr database without constraining m.w. or isoelectric point and with variable carbamidomethylation of cysteine and oxidation of methionine residues. One missed cleavage was allowed in the search parameters. Candidates with either protein score confidence interval or ion confidence interval .95% were considered significant.
Results
Anti-nucleolus autoantibodies are common in SLE patients
In clinical diagnosis, a common method to detect total autoantibodies is indirect immunofluorescence microscopy. In this study, we use isolated nucleoli and isolated nucleoplasmic fractions, FIGURE 3 . C1 protease degradation of proteins in the nucleoli and NG2. Isolated nucleoli (A) or the nuclear ghost fraction NG2 (B) were incubated with C1 for 0.5, 1, and 2 h at 37˚C. C1 was diluted from a Ca 2+ -depleted acidic buffer immediately before use. As controls, incubation was carried out for 2 h at 4˚C. These samples were then analyzed by SDS-PAGE on 12.5% (w/v) gels. As controls, C1, untreated nucleoli, or untreated NG2 were also included in the gels. Protein bands that clearly diminished following C1 incubation are indicated with arrowheads. Protein bands that appeared after C1 incubation are marked by asterisks (*). Molecular mass standards are labeled on the left. Representative data are shown for at least three independent experiments. Ghost, NG2. -depleted acidic buffer immediately before use. Nucleoli were incubated with C1 at 37˚C or, as a control, 4˚C for 2 h and then precipitated with trichloroacetic acid. Samples were then labeled with Cy2 (green) and Cy5 (red), respectively, and analyzed by 2D electrophoresis. (B) Based on merged signals, protein spots that exhibited orange color are considered insignificantly cleaved by C1 proteases. Those spots that exhibited dominant green signals are considered cleaved at 37˚C, but not 4˚C. Those exhibited dominant red signals are considered cleavage products. Spots that were picked for mass spectrometry are numerically labeled. pH standards are indicated at the bottom (pH 4-9). Molecular mass standards are indicated on both sides. The 2D-DIGE experiment was performed twice, but spots were picked in only one experiment. which are represented by the nuclear ghosts (NG1 and NG2) (48) , to detect these Abs. The homogeneity of isolated nucleoli was estimated based on the enrichment of two nucleolar proteins, NPM1 and NCL (Fig. 1B) . This was further validated by immunofluorescence staining of the nucleolus particles (Supplemental Fig. 1) .
Western blotting was performed to compare nucleoli with NG1 and NG2 for the presence of autoantigens. Fourteen SLE patient Abs were used (SLE37-50), which reacted heterogeneously with these three Ag sources (Fig. 1B) . All 14 patient Abs reacted with the nucleoli and also appeared to react with more Ag species in the nucleoli as compared with NG1 and NG2, except for patients SLE43, SLE46, and SLE48 (Fig. 1B) . These three patient Abs reacted more strongly with NG1, in which two autoantigens of 40 and 50 kDa, respectively, were recognized. These two nucleoplasmic autoantigens were either scarce or absent in the nucleoli. Normal human IgG also weakly reacted with a 50-kDa protein in NG1, which is absent in the nucleoli. This is consistent with SLE patients being known to develop heterogeneous anti-nuclear autoantibodies and the nucleoli being major targets of these Abs in some patients (49, 50) . These Western blotting results show that the nucleoli are broadly targeted by autoantibodies in SLE patients, although only in a subgroup of these patients are they the dominant Abs ( Fig. 1; data not shown) .
Structural features of nucleoli and the nuclear ghosts
Isolated nucleoli were particles of ∼1-3 mm in diameter (Fig. 1A,  Supplemental Fig. 1A ). These particles stained strongly for NPM1 (Supplemental Fig. 1B) . Based on the 0.38-mm section images, NPM1 formed a compact and continuous layer surrounding each nucleolus, and it overlapped with a surface layer of dense chromatins (Supplemental Fig. 1C, 1D ). These morphological features were more clearly observed at higher magnifications (Fig. 2B, 2C) . The nucleoli were also analyzed by scanning electron microscopy, which revealed consistent surface textures on different nucleolus particles (Fig. 2D, 2E , data not shown). These nonlipid surfaces of the nucleoli appeared dense and "capsid-like," and both singular (Fig. 2D) and interconnected (Fig. 2E) nucleoli could be isolated.
In contrast, NG2 exhibited an irregular and fragmental morphology in which chromatins appeared to be the backbone and NPM1 appeared as sporadic or discontinuous nodules affiliated to the chromatins (Supplemental Fig. 2A, 2B ). NG1 has similar morphology (data not shown). Through scanning electron microscopy, similar fragmental morphology was observed with NG2 ( Supplemental Fig. 2C ). Therefore, the nuclear ghost fractions, which represent the nucleoplasm, are clearly distinct from the nucleoli in both composition and structure. 
C1 proteases broadly degrade nucleolar proteins
To gauge the extent of nucleolar protein degradation by C1 proteases, we incubated nucleoli with C1 for 0.5, 1.0, and 2.0 h at 37˚C. As controls, nucleoli were either untreated or incubated with C1 for 2.0 h at 4˚C. Based on Coomassie blue staining, nucleoli that were treated at 4˚C exhibited an overall similar protein profile to untreated nucleoli, suggesting insignificant degradation (Fig. 3A) . However, those incubated with C1 at 37˚C showed time-dependent degradation of some otherwise abundant proteins in the 110-, 65-, 36-, and 28-kDa regions (Fig. 3A) . Those in the 110-and 36-kDa regions were predicted to contain NCL and NPM1, respectively (48) . In contrast, a prominent 23-kDa protein species appeared after C1 incubation, which may correspond to a proteolytic fragment. It was also noted that many nucleolar proteins were not significantly degraded, including core histones and other proteins that migrated in the 10-to 15-kDa region. NG2 showed different protein profiles in which the 110-, 65-, and 36-kDa regions were not particularly abundant with proteins (Figs. 1B, 3B) . However, the 28-kDa region in NG2 was similarly abundant with protein as in the nucleoli and was also cleaved by C1 proteases (Fig. 3B) . This experiment revealed the broad but selective susceptibility of nucleolar proteins to C1 degradation. However, it lacked the resolution for protein identification and the sensitivity to view less abundant proteins.
Proteomic profiling of C1-cleavable nucleolar proteins
To determine the identities of these C1-cleavable nucleolar proteins, we resolved the C1-treated nucleoli in two dimensions through two-dimensional fluorescence difference gel electrophoresis (2D-DIGE). As illustrated in Fig. 4A , nucleoli were treated for 2.0 h with C1 at 4˚C, which were then labeled with Cy2 (green). Those treated at 37˚C were subsequently labeled with Cy5 (red). The two samples were combined equivalently and resolved by 2D electrophoresis. Most proteins were found similarly represented by Cy2 and Cy5 as orange spots, suggesting insignificant degradation at 37˚C (Fig. 4B) . However, some protein spots were overrepresented by either Cy2 or Cy5. We proposed that those overrepresented by Cy2 (green) indicated their degradation at 37˚C and therefore were underrepresentative of their Cy5-labeled forms in the expected spots. Those overrepresented by Cy5 (red) were likely to be new proteolytic fragments. Greater than 200 proteins were collected, and some were further analyzed by MALDI-TOF and TOF/TOF.
A total of 42 protein spots gave rise to conclusive data: 28 Cy2-dominant and 14 Cy5-dominant proteins. Seven protein spots were identified as NCL or its proteolytic fragments (Tables I, II) . This was consistent with our earlier observation that NCL was cleaved by C1 proteases (48) . Four protein spots were identified as NPM1 or its fragments, which was also anticipated (48, 54) . One Cy2-dominant protein of ∼80 kDa (spot 2) was identified as C1s and, based on the size, it corresponded to the proenzyme form of C1s (Table I) . Two Cy5-dominant proteins of ∼55 kDa (spot 30) and 27 kDa (spot 87), respectively, were also identified as C1s, which were most likely to be the H and L chains of activated C1s (Table II) . The remaining 28 spots represented 22 distinct protein identities, which were not previously known to be cleavable by C1 proteases. This data set focused only on more abundant proteins, and the actual number of C1-degradable nucleolar proteins is likely to be greater. Our results resonate with an earlier prediction that, besides its complement substrates, C1s potentially cleaves many intracellular proteins (55) . In fact, C1s is also known to cleave cell surface receptors and the secreted insulin-like growth factor binding protein 5 (56) .
C1 degradation of nucleolar proteins attributes to its C1r/C1s proteases
To validate these newly identified nucleolar substrates for the C1 proteases, C1-treated nucleoli were subjected to Western blotting using specific Abs. Initial experiments showed that different nucleolar proteins exhibited varying sensitivities to C1 cleavage. Therefore, nucleoli were again treated with C1 for 0.5, 1.0, or 2.0 h at 37˚C as shown in Fig. 3A . As controls, nucleoli were also incubated at 37˚C without C1. Abs were obtained for BOP1, RRP9, DDX5, DDX21, hnRNPC, hnRNPA2B1, EIF2S1, SFPQ, and RPL30. In addition, Abs for C1q and C1s, the nucleolar proteins NPM1, NCL, and fibrillarin, histones H3, H1.2, and H1.x, and heterogeneous nuclear ribonucleoprotein U (hnRNPU) were also included in this experiment.
As previously observed (48), NPM1 and NCL were degraded by C1 in a time-dependent manner (Fig. 5) . In these reactions, the inputs of C1 were identified based on the levels of C1q and C1s. The activation status of C1s was apparent because it was converted from its larger proenzyme form to its activated H (55 kDa) and L (27 kDa) chains (Fig. 5) . Without C1, incubation of nucleoli alone caused undetectable NPM1 or NCL degradation (Fig. 5) . When C1-inh was included in these reactions, NPM1 and NCL degradation was inhibited to varying extents, showing the Spot ID corresponds to the number assigned to a picked spot from the 2D-DIGE analysis (Fig. 4) .
involvement of C1 proteases (Fig. 5) . We noticed that the anti-C1s Ab recognized, besides the three major bands corresponding to proenzyme C1s and its H and L chains, numerous other minor bands. This cannot be simply explained because, with human serum and the isolated C1 complex, the Ab only recognized C1s (Supplemental Fig. 3 ). The Ab also showed no recognition of nucleolar proteins (Fig. 5) . With C1 treatment, SFPQ, BOP1, EIF2S1, and hnRNPC1 diminished, leaving no proteolytic fragments that remained detectable by the Abs used (Fig. 5) . DDX5, DDX21, hnRNPA2B1, RRP9, and RPL30 were also degraded with C1 incubation and, for these new C1 substrates, proteolytic fragments were detectable by the Abs used (Fig. 5) . For most of these new C1 substrates, cleavage was apparent at 0.5 h, but BOP1, hnRNPA2B1, and RRP9 appeared more resistant to C1 degradation. A significant fraction of BOP1 remained intact after incubation with C1 for 2.0 h. In contrast, SFPQ, DDX5, and EIFS1 were completely cleaved within 1.0 h (Fig. 5) . Fibrillarin and histone H3 appeared to resist C1 degradation. Histones H1.2 and H1.x and the nucleoplasmic protein hnRNPU, which were not identified in the 2D-DIGE experiment, were also degraded. Where a protein was found degraded by C1, this was always inhibited by C1-inh (Fig. 5) , suggesting pivotal contributions of the C1r/C1s proteases in the observed proteolytic degradation.
The nucleoli are poorly autoproteolytic
Cells contain abundant intracellular proteases and are therefore intrinsically autoproteolytic (57) . However, a careful inspection of the Western blotting data revealed that, unless C1 was added, the nucleoli exhibited little protein degradation after incubation for up to 2 h at 37˚C (Fig. 5) . It suggests that the nucleoli contain little active proteases and are therefore poorly autoproteolytic. This may preserve their antigenicity in dead cells. DDX21 was an exception because, without C1, it still underwent degradation, which reduced its molecular mass from 90 to 70 kDa. C1 proteases increased DDX21 degradation, but neither C1-mediated nor self-proteolytic degradation reduced DDX21 below a 70-kDa fragment (Fig. 5 ). It appears that the two types of cleavage sites are FIGURE 5. Validation of nucleolar protein cleavage by C1 proteases. After 2D-DIGE analysis, selected protein spots were analyzed by MALDI-TOF and TOF/TOF. The identified proteins were validated by Western blotting. In brief, nucleoli were incubated with C1 for 0.5, 1, and 2 h at 37˚C. C1 was diluted from a Ca 2+ -depleted acidic buffer immediately before use. As controls, nucleoli were incubated alone. Nucleoli were also incubated with C1 in the presence of the C1-inh. The protein profiles of each sample were shown by Coomassie blue staining (Supplemental Fig. 4 ). Samples were then analyzed by Western blotting with Abs specific for BOP1, DDX5, DDX21, SFPQ, EIF2S1, HNRNPC, HNRNPA2B1, RRP9, RPL30, and, as controls, with Abs specific for C1q, C1s, NCL, and NPM1. Molecular mass standards are indicated on the left. Two representative H1 histones H1.2 and H1.x and hnRNPU, which were not among the picked spots, were also included. Representative data are shown for at least two independent experiments. confined to a 20-kDa terminal region on DDX21. Nonetheless, these preserved nucleolar proteins may induce autoantibodies. The targeting of C1 proteases to these nucleolar Ags through C1q could be one mechanism in the dismantling of nucleolar autoantigenicity to reduce anti-nuclear autoantibodies induction.
Many nucleolar autoantigens are cleaved by C1 proteases
Because the isolated nucleoli were broadly recognized by SLE patient autoantibodies (Fig. 1B) , we asked whether these autoantigens might be degraded by C1 proteases. After incubation with C1 for 2 h at 37˚C, nucleoli were then analyzed by Western blotting using SLE patient autoantibodies. As a control, nucleoli were incubated with C1 at 4˚C. With 10 SLE patient Abs, at least 25 autoantigens were found degraded after C1 treatment at 37˚C, although the protein identities of these autoantigens were not defined (Fig. 6) . Besides, five autoantigen fragments were detected after C1 treatment at 37˚C. It was also noted that a significant number of autoantigens were not affected after C1 treatment.
Our results have revealed that nucleoli are intrinsically poor in self-proteolysis, and this can contribute to their broad autoantigenicity in SLE patients. However, we also revealed that nucleolar proteins or autoantigens are broadly but selectively degraded by C1 proteases, which can be targeted to apoptotic nucleoli through C1q (48) . Collectively, our data help explain the high autoantigenicity of the nucleoli and the strong association between C1 deficiency and the development of anti-nuclear autoantibodies and SLE disease (Fig. 7) .
Discussion
Anti-nuclear autoantibodies contribute to diseases by forming injurious immune complexes (14, 15) . Aberrant cell death and impaired immune clearance are believed to expose nuclear Ags to inflammatory or immunogenic contexts and induce these Abs (11, 13, 18, 20) . How anti-nuclear autoantibodies are induced remains poorly understood, but cases of homozygous deficiencies of C1q, C1r/C1s, or C4 are informative because they mostly cause these autoantibodies and the SLE disease (23, 28, 58) .
In the quest to understand how these genetic deficiencies contribute to SLE, studies have mostly emphasized individual genes. For C1q, previous articulations drew mainly from two lines of investigation: C1q opsonizes apoptotic cells for effective clearance (13, 40, 41) , and C1q inhibits DC and macrophage responses (45, 46, (59) (60) (61) . The fact that C1q complexes with C1r and C1s in vivo was mostly not considered. How C1r/C1s deficiency also causes these autoantibodies has not been investigated. This study stemmed from the recent finding that C1q specifically targeted nucleoli in dead cells, which caused C1s activation and the degradation of two nucleolar autoantigens (48) . Considering that the nucleoli are also major targets of autoantibodies (49, 50) , we hypothesized that C1 complexes broadly dismantle nucleolar proteins and autoantigens to diminish their autoantigenicity. Our data support this hypothesis.
The context where C1q was first found to bind to the nucleoli was in late apoptotic cells (48) . However, this cellular context was overly heterogeneous and complex for proteomic identification of C1-cleaved nucleolar proteins. Nucleoli were therefore isolated to incubate with C1. Using 2D-DIGE, we found many nucleolar proteins to be degraded after C1 treatment, among which 22 nucleolar proteins represented novel substrates for the C1 proteases. Abs were available to validate independently by Western blotting that some of these nucleolar proteins were indeed cleavable by C1 proteases.
In this study, it could not be concluded whether C1r or C1s cleaved these nucleolar proteins. Within the C1 complex, C1r and Schematic illustration of C1 complex responses to nucleoli in live, apoptotic, and necrotic cells. In live cells, the surface membrane is impermeable to extracellular C1q, which excludes C1 proteases (C1r and C1s) from all intracellular protein substrates including nucleolar proteins. Early apoptotic cells remain impermeable to extracellular C1q and the C1r/ C1s proteases. These cells also conceal intracellular Ags from autologous immune responses. In necrotic cells, nucleolar Ags are exposed to autologous immune responses, but they also become accessible to C1 and susceptible to C1q-mediated degradation by C1r/C1s proteases. C1s activation on nucleoli could also lead to C4b deposition and C4b-mediated clearance and tolerance induction.
C1s are two similar serine proteases that exist in their proenzyme forms. In the context of the complement system, C1q causes C1r activation after its binding to ligands, and C1r then cleaves and activates C1s, the only known activity of C1r (30, 31) . C1s then cleaves C4 and C2. C1-inh binds to the activated, but not the proenzyme, form of C1r 2 C1s 2 complex to block its proteolytic activities. The pivotal contribution of the C1 proteases to the C1-mediated nucleolar protein cleavage can be concluded based on the observed inhibition by C1-inh, although it cannot be determined which C1 protease cleaved these nucleolar proteins. Nonetheless, it can be inferred that C1q targets these C1 proteases to nucleoli, and these proteases collaborate to degrade many nucleolar proteins or autoantigens, which is one compelling explanation why C1q or C1r/C1s deficiency often causes anti-nuclear autoantibodies and SLE disease (Fig. 7) .
The poor autoproteolysis of nucleoli potentially preserves the antigenicity of nucleolar proteins and the activity of nucleolar DAMPs during cell apoptosis. Even though cytoplasmic proteases may contribute to nuclear autoantigen degradation during cell apoptosis (62), the C1 complex may represent an important exogenous surveillance mechanism that helps safeguard against nucleolar autoimmunogenicity by dismantling these Ags and alarmins (Fig. 7) . The broad tissue production of C1q and C1r/C1s by macrophages and DCs is consistent with such a role for C1 (63) (64) (65) . Having stressed the potential importance of this novel mechanism, we also understand that the causes of anti-nuclear autoantibodies and SLE disease are complex and are not explained by single mechanisms. For example, because C1s is effectively activated after C1 incubation with the nucleoli, it is also expected to cleave C4 and cause C4b deposition on the nucleoli to trigger C4b-mediated clearance and B cell tolerance (13, 43, 44) .
Nonetheless, immunogenicity necessitates both Ags and adjuvant signals. Whether the nucleoli are sufficient to cause anti-nuclear autoantibodies awaits further examination. Data in Fig. 1 suggest that most SLE patients develop some levels of anti-nucleolar autoantibodies, although in the majority of SLE patients, these Abs may not be identified as the dominant specificities by the widely used indirect immunofluorescence method (49) (data not shown). If nucleoli indeed induce autoantibodies as primary immunogens, it would imply the presence of intrinsic adjuvant elements. In this context, C1 proteases have been found to cleave the nuclear DAMP HMGB1 and inactivate its adjuvant activity (54, 66) .
